Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Therapix Biosciences Ltd. (TRPX)

0.5001   -0.113 (-18.42%) 02-28 15:59
Open: 0.61 Pre. Close: 0.613
High: 0.6147 Low: 0.5
Volume: 354,579 Market Cap: 4M
Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. The Company is engaged in creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.611 - 0.614 0.614 - 0.617
Low: 0.494 - 0.497 0.497 - 0.499
Close: 0.496 - 0.5 0.5 - 0.504

Technical analysis

as of: 2020-02-28 4:33:01 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 0.66     One year: 0.77
Support: Support1: 0.41    Support2: 0.34
Resistance: Resistance1: 0.56    Resistance2: 0.66
Pivot: 0.50
Moving Average: MA(5): 0.52     MA(20): 0.50
MA(100): 1.34     MA(250): 2.32
MACD: MACD(12,26): -0.06     Signal(9): -0.09
Stochastic oscillator: %K(14,3): 51.85     %D(3): 53.22
RSI: RSI(14): 42.41
52-week: High: 4.76  Low: 0.41  Change(%): -89.3
Average Vol(K): 3-Month: 20617  10-Days: 25954

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TRPX has closed above bottom band by 47.4%. Bollinger Bands are 75% narrower than normal. The narrow width of the bands suggests low volatility as compared to TRPX's normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2020-02-27
Therapix Biosciences Ltd. Receives Nasdaq Notification Regarding Minimum Bid Requirements
TEL AVIV, Israel, Feb. 27, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today that on February 24, 2020, the Company received a written notice from…

2020-02-06
Nasdaq Hearings Panel Grants Therapix Biosciences Extension to Regain Compliance With Listing Requirements
TEL AVIV, Israel, Feb. 6, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today that on February 5, 2020, it received notice that the Nasdaq Hearings…

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 7.22
Shares Float (M) 4.05
% Held by Insiders 9.73
% Held by Institutions
Shares Short (K) 149
Shares Short P. Month (K)

Stock Financials

EPS -2.798
Book Value (p.s.) -0.180
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -111.5
Return on Equity (ttm) -362.8
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.007
Qtrly Earnings Growth
Operating Cash Flow (M) -6.56
Levered Free Cash Flow (M) -3.01

Stock Valuations

P/E -0.18
P/E Growth Ratio -0.18
P/BV -2.78
P/S
P/CF -0.55

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2016-12-08
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.